Curelo raises USD 100k from IIMA’s CIIE.CO

Curelo, founded in 2022 by Dr Arpit Jayswal, which enables patients to book at-home blood sample collection and receive timely blood reports from any labs of their preference, announced that it has raised $100k from IIMA’s CIIE.CO. The platform is powered by a fleet of phlebotomists that can collect samples within 60 minutes of booking and deliver them to the selected lab. Patients can also discover a lab on the platform based on test availability, pricing, and turnaround time.

In the last 10 months of operations, Curelo has partnered with 1350+ labs, processed over 125,000 orders, and is currently generating a monthly run rate of INR 55 Lacs at a month on month growth of 30%. Curelo also aims to expand its footprint in radiology and blood bank aggregators in the near future.

Vipul Patel, Partner – Seed Investments at CIIE.CO, said, “The fragmented diagnostic market, commanding an 85% market share, is composed of standalone and hospital-based labs. Whereas, the top four corporate diagnostics chains in India hold a mere 6% share. Arpit’s experience in running a chain of multi-specialty hospitals and diagnostic labs gives him deep insights into the customer pain points. We are excited to partner with the Curelo team and look forward to helping them scale their business.”

Dr Arpit Jayswal, Curelo’s Founder and CEO, remarked ”We are excited to have CIIE.CO back Curelo. Their conviction reflects the immense potential in our platform and the diagnostic aggregator sector. Our primary focus is scaling nationwide, optimizing user experience, and standardizing sample collection, aiming to serve 1000+ home samples daily by year-end. We are keen to have CIIE.CO support us in this journey with their exceptional sector understanding and network”

This investment marks a significant milestone for Curelo and positions the company to continue its growth trajectory in the highly competitive Indian healthcare market. IndianWeb2